Transchem Share News - Latest Updates, Live News & More

Latest news about Transchem

Transchem Limited Publishes Audited FY26 Results via Newspaper Ad Under Regulation 47 4 days ago

Transchem Limited confirmed the newspaper publication of its audited financial results for the quarter and year ended March 31, 2026, via a Regulation 47 filing with BSE on May 07, 2026. The company reported a Q4 net profit of ₹208.32 lakh and a full-year net profit of ₹429.51 lakh, with total income of ₹926.08 lakh for FY26. The Board also re-appointed M/s. L. T. Jadav & Co. as Internal Auditors for FY27 and disclosed a pending warrant issuance of up to 6,15,00,000 warrants at ₹75 per warrant.

Transchem Limited Declares Non-Applicability of Large Entities Framework for FY26 Apr 15, 2026

Transchem Limited Submits Quarterly Compliance Certificate for Q4FY26 Apr 08, 2026

Transchem Limited Reports 62% Decline in Q3FY26 Net Profit to ₹52.94 Lakhs Feb 07, 2026

Transchem Limited Completes MOA Alteration Following Rs. 461.25 Crore Warrant Approval Dec 22, 2025

More news about Transchem

16Oct 25

Transchem Reports Strong Q2 FY2026 Results, Plans Strategic Acquisition

Transchem announced robust Q2 and H1 FY2026 results, with Q2 net profit at ₹67.92 crores and H1 net profit at ₹167.25 crores. The company plans to acquire 100% equity in Greshma Shares & Stocks Limited (GSSL), a stock broking and financial services firm. The acquisition, subject to approvals, will diversify Transchem's portfolio into financial services. GSSL reported an annual turnover of ₹11.32 crores and net worth of ₹15.89 crores as of March 2025. Transchem also adopted new Articles of Association and amended its Memorandum of Association.

16Oct 25

Transchem Limited Shareholders Approve New Articles of Association and Memorandum Amendments

Transchem Limited (BSE: 500422) held an Extraordinary General Meeting on October 16, 2025, where shareholders unanimously approved two special resolutions. The first adopts new Articles of Association aligned with the Companies Act, 2013. The second amends the Memorandum of Association, expanding business objectives to include broking services, financial advisory, technology integration, and depository participant activities. Both resolutions received 8,263,482 votes in favor, with 100% approval.

23Sept 25

Transchem Limited Pivots to Financial Services, Approves New Articles and Memorandum of Association

Transchem Limited is shifting its business focus from natural products and pharmaceuticals to financial services. The Board approved this change on September 23, along with new Articles of Association and Memorandum of Association. The company plans to enter stockbroking, portfolio management, fund management, and act as a depository participant. This strategic shift aims to leverage advanced technologies and is subject to shareholder approval at an upcoming Extraordinary General Meeting.

07Aug 25

Transchem Limited Reports 40% Drop in Q1 Net Profit Amid Revenue Decline

Transchem Limited (BSE: 500422) reported a significant decline in financial performance for Q1 2025. Total income decreased by 33.77% to ₹163.58 lakhs, while net profit fell by 40.24% to ₹99.33 lakhs compared to Q1 2024. The company reported no revenue from operations, with income solely from other sources. Despite the revenue decline, total expenses remained relatively stable at ₹28.48 lakhs. Basic EPS decreased to ₹0.81 from ₹1.36 in the previous year. The company's paid-up equity share capital stands at ₹1,224 lakhs, with other equity at ₹6,707.54 lakhs as of March 31.

Transchem

195.15

+9.25

(+4.98%)

1 Year Returns:0.00%

Industry Peers

Sun Pharmaceutical

1,872.70

(+1.34%)

Divis Laboratories

6,714.00

(+0.05%)

Torrent Pharmaceuticals

4,517.10

(+3.11%)

Dr Reddys Laboratories

1,279.90

(-1.08%)

Cipla

1,304.90

(-3.13%)

Lupin

2,255.90

(-5.19%)

Mankind Pharma

2,468.80

(+1.56%)

Zydus Life Science

956.95

(+1.80%)

Aurobindo Pharma

1,486.60

(-0.05%)

Laurus Labs

1,266.80

(+3.13%)

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104